JSNM/ESMIT – SPECT and PET in the Contemporary Assessment of Cardiac Amyloidosis

This joint webinar will provide a focused and clinically relevant overview of the role of nuclear medicine in the evaluation of cardiac amyloidosis. The first lecture will address the established value of bone-avid tracer SPECT/CT for non-invasive diagnosis, including acquisition strategy, image interpretation, common pitfalls and integration with the broader diagnostic work-up. The second lecture will explore the evolving contribution of PET, highlighting tracer biology, quantitative opportunities, disease characterization and the potential role of PET for earlier detection and treatment monitoring. Together, the two talks will offer attendees a practical and up-to-date framework for understanding how SPECT and PET can complement each other along the diagnostic and management pathway of patients with suspected or confirmed cardiac amyloidosis.

• Review the current role of bone-avid tracer SPECT/CT in the non-invasive diagnosis of cardiac amyloidosis, including key interpretation criteria and diagnostic pitfalls.
• Understand the emerging value of PET in cardiac amyloidosis, with emphasis on tracer selection, disease characterization, quantification and future clinical applications.
• Integrate nuclear medicine findings into a multidisciplinary diagnostic pathway, improving confidence in image interpretation and supporting patient-centered clinical decision-making.

Nuclear Medicine physicians, Cardiologists with a focus on cardiovascular imaging, Radiologists, Internists involved in amyloidosis care, Technologists, Fellows and Residents.